radiomics.bio

radiomics.bio, founded in 2016, is a Belgium-based imaging research company that is revolutionizing the healthcare industry by leveraging AI, Biotechnology, and Health Care expertise. The startup specializes in Radiomics, Deep Learning, and Federated Learning, with a strong focus on oncology and personalized medicine.

With its roots in pioneering radiomics science, radiomics.bio aims to transform conventional medical images into rich data sources, unlocking hidden insights to support strategic decision-making in drug development and clinical trials. Their innovative approach is designed to enhance the efficiency and precision of pharmaceutical and biotech research, ultimately advancing patient-centered healthcare solutions.

Though the company has not disclosed any recent investment activities, its continuous collaboration with both national and international partners signifies a robust R&D foundation. This positions radiomics.bio as an attractive opportunity for investors looking to be at the forefront of AI-powered drug development and personalized healthcare.